Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 4Other solid neoplasm 3Tumor-Agnostic 2Other 2Lymphoid 2Plasma cell 1Other neoplasm 1Other hematologic neoplasm 1Myeloid 1Gastrointestinal 1

Conditions

Hematopoietic and Lymphoid System Neoplasm 1

Interventions

fludarabine 5Educational Status 5fludarabine phosphate 4Whole-Body Irradiation 4Mycophenolic Acid 4Methods 4Melphalan 4Magnetic Resonance Spectroscopy 4Early Intervention, Educational 4Cyclophosphamide 4Busulfan 4Biopsy 4Taxes 3Tacrolimus 3Specimen Handling 3Peripheral Blood Stem Cell Transplantation 3Paclitaxel 3Interviews as Topic 3venetoclax 2Sirolimus 2Patient Reported Outcome Measures 2Nivolumab 2Mesna 2Health Promotion 2Colposcopy 2Cisplatin 2Aminolevulinic Acid 2Albumin-Bound Paclitaxel 2toripalimab 1tirbanibulin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Mindfulness × Other neoplasm × 1 year × Clear all
NCT06030427 2025-10-24

Virtual Mindfulness and Weight Management to Mitigate Risk of Relapse and Improve Wellbeing in Cancer Survivors

Mayo Clinic

Phase NA Completed
19 enrolled
OtherOther neoplasmOther solid neoplasm

Hematopoietic and Lymphoid System Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡